Texas Attorney General Ken Paxton announced October 27 that Texas Children’s Hospital has opened a “detransition clinic” required by a settlement with his office. The clinic is accepting appointment requests for people seeking care related to detransition.
Paxton calls it a victory against what he describes as “gender ideology.” The hospital describes something more specific: a multidisciplinary service offering individualized care for patients through age 21, along with detransition-related obstetric and gynecological care for older patients. Its listed specialties include endocrinology, surgery, psychiatry, psychology and social work.
People who stop or reconsider transition-related treatment deserve competent care and a hearing on their own terms. That care is not inherently conversion therapy. The hospital’s public description does not tell us that patients will be pressured to change their identities or directed toward an outcome they have not chosen.
What is clear is Paxton’s role in creating the program. According to his office, the settlement requires Texas Children’s to fund the clinic for five years, pay $10 million and permanently terminate the privileges of multiple physicians. It also requires changes to hospital bylaws concerning gender-transition interventions.
That makes the clinic a product of legal and political pressure as well as a medical service. It also makes it especially important to distinguish the needs of patients from the story Paxton is telling about them.
What the numbers do and do not show
The clinic’s services include surgery, but that does not establish that its prospective patients underwent surgery as minors. Nor are all of its patients necessarily minors: the hospital says it will treat people through age 21 and provide some services beyond that age.
Gender-affirming surgery among minors has occurred, but it is rare. A 2024 study in JAMA Network Open identified 85 such procedures among minors in the insurance data it examined; 82 were chest-related, and none were identified among children 12 or younger.
Care for adolescents can also involve medication rather than surgery. A 2025 study in JAMA Pediatrics examined puberty blockers and hormones in privately insured adolescents and found both were uncommon. Hormone treatment was more frequent than puberty blockers in that sample. Neither study tells us what treatments patients at the new clinic received.
Research on regret also deserves a place in the discussion. A 2021 review of 27 studies, encompassing 7,928 patients who underwent gender-affirming surgery, estimated reported regret at about 1%. A 2023 study of gender-affirming mastectomy found very high satisfaction among its 139 respondents.
Those findings have limitations, including differences in follow-up and in how regret was measured. They do not establish a single satisfaction rate for all forms of transition care or for every age group. They do, however, challenge any suggestion that regret is the usual outcome.
Detransition, stopping medication and regretting treatment are distinct experiences. Some people who stop treatment do so for reasons other than regret or a change in identity. Each person’s account deserves attention without being made to stand for everyone else.
Whose decisions?
Paxton’s announcement describes people receiving care as victims of an ideology he intends to defeat. That is his political characterization, not a finding about the experience of every patient who seeks the clinic’s help.
The practical questions are more useful. Will patients be free to describe their experiences without being steered toward a particular identity? Will their goals guide their care? Will the hospital publish enough information about its approach for patients and families to understand what is offered?
People who regret or reconsider treatment should have somewhere to turn. Their experiences also should not be used to erase the experiences of those who benefit from gender-affirming care, or to dismiss decisions made by patients, parents and clinicians together.
For now, the clinic’s existence and its services are documented. Its clinical practices and patient outcomes remain to be seen. Those, rather than Paxton’s rhetoric, will be the meaningful measures of whom it helps and how.
This post was created with the help of AI. See details.